Se ha administrado un tratamiento de terapia celular avanzada llamado ViroTCell, que toma defensas de personas sanas y las activa para que actúen como medicamento contra las infecciones virales de lo...
Read moreResearchers at the Centre for Genomic Regulation (CRG) in Barcelona have contributed to the creation of new guidelines to improve the clarity, interpretability, and reproducibility of microscopy image...
Read moreIt has been conducted a study to analyze cough sounds recorded by smartphones in patients with COVID-19. The results reveal cough characteristics that could offer a quick, easy, and cost-effective met...
Read moreChildren whose mothers had a higher exposure to certain phthalates during pregnancy tend to show smaller total gray matter in their brains at age 10.
Read moreA study in the journal Cell sheds new light on the evolution of neurons, focusing on the placozoans, a millimetre-sized marine animal. Researchers at the Centre for Genomic Regulation in Barcelona fin...
Read moreEn el mayor estudio realizado hasta la fecha sobre la relación entre la psoriasis grave y la disfunción microvascular coronaria (DMC), un equipo científico, encabezado por investigadores de la Univ...
Read moreLos resultados obtenidos apoyan el uso de pruebas moleculares para el diagnóstico del cáncer de endometrio y destacan los beneficios potenciales de esta estrategia para incrementar el número de cas...
Read moreIt has been revealed that the exposure of European adolescents to perfluorinated substances (PFAS) may have harmful consequences on their reproductive health. This shocking finding has been possible t...
Read moreIt has been shown that placophilin-2 protein (PKP2) is important for adipose cell viability and fat function, and that its presence is compromised in people with obesity.
Read moreHasta ahora las terapias se han enfocado en eliminar las sustancias tóxicas que se acumulan en el cerebro de los pacientes o en la neurodegeneración, por lo que el actual estudio podría aportar un ...
Read more3P Biopharmaceuticals and the Swedish company, Toleranzia AB, have successfully accomplished 1000 L full-scale GMP manufacturing of TOL2 drug substance destinated to be used in clinical study.
Read more